These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

458 related articles for article (PubMed ID: 19731042)

  • 1. Microglia in ALS: the good, the bad, and the resting.
    Henkel JS; Beers DR; Zhao W; Appel SH
    J Neuroimmune Pharmacol; 2009 Dec; 4(4):389-98. PubMed ID: 19731042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Wild-type microglia extend survival in PU.1 knockout mice with familial amyotrophic lateral sclerosis.
    Beers DR; Henkel JS; Xiao Q; Zhao W; Wang J; Yen AA; Siklos L; McKercher SR; Appel SH
    Proc Natl Acad Sci U S A; 2006 Oct; 103(43):16021-6. PubMed ID: 17043238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transformation from a neuroprotective to a neurotoxic microglial phenotype in a mouse model of ALS.
    Liao B; Zhao W; Beers DR; Henkel JS; Appel SH
    Exp Neurol; 2012 Sep; 237(1):147-52. PubMed ID: 22735487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulatory T lymphocytes from ALS mice suppress microglia and effector T lymphocytes through different cytokine-mediated mechanisms.
    Zhao W; Beers DR; Liao B; Henkel JS; Appel SH
    Neurobiol Dis; 2012 Dec; 48(3):418-28. PubMed ID: 22820142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extracellular mutant SOD1 induces microglial-mediated motoneuron injury.
    Zhao W; Beers DR; Henkel JS; Zhang W; Urushitani M; Julien JP; Appel SH
    Glia; 2010 Jan; 58(2):231-43. PubMed ID: 19672969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ablation of proliferating microglia does not affect motor neuron degeneration in amyotrophic lateral sclerosis caused by mutant superoxide dismutase.
    Gowing G; Philips T; Van Wijmeersch B; Audet JN; Dewil M; Van Den Bosch L; Billiau AD; Robberecht W; Julien JP
    J Neurosci; 2008 Oct; 28(41):10234-44. PubMed ID: 18842883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired recruitment of neuroprotective microglia and T cells during acute neuronal injury coincides with increased neuronal vulnerability in an amyotrophic lateral sclerosis model.
    Kawamura MF; Yamasaki R; Kawamura N; Tateishi T; Nagara Y; Matsushita T; Ohyagi Y; Kira J
    Exp Neurol; 2012 Apr; 234(2):437-45. PubMed ID: 22293437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of amyotrophic lateral sclerosis-linked SOD1 mutant increases the neurotoxic potential of microglia via TLR2.
    Liu Y; Hao W; Dawson A; Liu S; Fassbender K
    J Biol Chem; 2009 Feb; 284(6):3691-9. PubMed ID: 19091752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroinflammation modulates distinct regional and temporal clinical responses in ALS mice.
    Beers DR; Zhao W; Liao B; Kano O; Wang J; Huang A; Appel SH; Henkel JS
    Brain Behav Immun; 2011 Jul; 25(5):1025-35. PubMed ID: 21176785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The microglial-motoneuron dialogue in ALS.
    Appel SH; Zhao W; Beers DR; Henkel JS
    Acta Myol; 2011 Jun; 30(1):4-8. PubMed ID: 21842586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune reactivity in a mouse model of familial ALS correlates with disease progression.
    Alexianu ME; Kozovska M; Appel SH
    Neurology; 2001 Oct; 57(7):1282-9. PubMed ID: 11591849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A system mathematical model of a cell-cell communication network in amyotrophic lateral sclerosis.
    Shao H; He Y; Li KC; Zhou X
    Mol Biosyst; 2013 Mar; 9(3):398-406. PubMed ID: 23287963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD4 + T Cells and Neuroprotection: Relevance to Motoneuron Injury and Disease.
    Jones KJ; Lovett-Racke AE; Walker CL; Sanders VM
    J Neuroimmune Pharmacol; 2015 Dec; 10(4):587-94. PubMed ID: 26148561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD4+ T cells support glial neuroprotection, slow disease progression, and modify glial morphology in an animal model of inherited ALS.
    Beers DR; Henkel JS; Zhao W; Wang J; Appel SH
    Proc Natl Acad Sci U S A; 2008 Oct; 105(40):15558-63. PubMed ID: 18809917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. System xC- is a mediator of microglial function and its deletion slows symptoms in amyotrophic lateral sclerosis mice.
    Mesci P; Zaïdi S; Lobsiger CS; Millecamps S; Escartin C; Seilhean D; Sato H; Mallat M; Boillée S
    Brain; 2015 Jan; 138(Pt 1):53-68. PubMed ID: 25384799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of activated microglia in increased vulnerability of motoneurons after facial nerve avulsion in presymptomatic amyotrophic lateral sclerosis model rats.
    Sanagi T; Nakamura Y; Suzuki E; Uchino S; Aoki M; Warita H; Itoyama Y; Kohsaka S; Ohsawa K
    Glia; 2012 May; 60(5):782-93. PubMed ID: 22344792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The NADPH oxidase pathway is dysregulated by the P2X7 receptor in the SOD1-G93A microglia model of amyotrophic lateral sclerosis.
    Apolloni S; Parisi C; Pesaresi MG; Rossi S; Carrì MT; Cozzolino M; Volonté C; D'Ambrosi N
    J Immunol; 2013 May; 190(10):5187-95. PubMed ID: 23589615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-10 Controls Early Microglial Phenotypes and Disease Onset in ALS Caused by Misfolded Superoxide Dismutase 1.
    Gravel M; Béland LC; Soucy G; Abdelhamid E; Rahimian R; Gravel C; Kriz J
    J Neurosci; 2016 Jan; 36(3):1031-48. PubMed ID: 26791230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Actions of the antihistaminergic clemastine on presymptomatic SOD1-G93A mice ameliorate ALS disease progression.
    Apolloni S; Fabbrizio P; Amadio S; Volonté C
    J Neuroinflammation; 2016 Aug; 13(1):191. PubMed ID: 27549088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NF-κB activation in astrocytes drives a stage-specific beneficial neuroimmunological response in ALS.
    Ouali Alami N; Schurr C; Olde Heuvel F; Tang L; Li Q; Tasdogan A; Kimbara A; Nettekoven M; Ottaviani G; Raposo C; Röver S; Rogers-Evans M; Rothenhäusler B; Ullmer C; Fingerle J; Grether U; Knuesel I; Boeckers TM; Ludolph A; Wirth T; Roselli F; Baumann B
    EMBO J; 2018 Aug; 37(16):. PubMed ID: 29875132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.